Product Images Dexedrine Spansule

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Dexedrine Spansule NDC 64896-674 by Amneal Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

DEXEDRINE - Chemical Structure - dexedrine dextroamphetamine sulfate spansule susta 1

DEXEDRINE - Chemical Structure - dexedrine dextroamphetamine sulfate spansule susta 1

symbol for schedule two controlled drug substance - dexedrine dextroamphetamine sulfate spansule susta 2

symbol for schedule two controlled drug substance - dexedrine dextroamphetamine sulfate spansule susta 2

This is a medication guide for Dexedrine Spansule sustained-release capsules, containing dextroamphetamine sulfate, used for treating attention deficit hyperactivity disorder (ADHD). The capsules should be stored at controlled room temperature between 20°C and 25°C, dispensed in a tight, light-resistant container with safety closures, and come in 5mg dosage. The medication is gradually released over a prolonged period. It is manufactured by Catalent Pharma Solutions and distributed by Amineal Specialty, a division of Amneal Pharmaceuticals, both located in the United States. The guide also includes a warning regarding the Federal law requiring dispensing Dexedrine with a Medication Guide and the Lot and Exp. Date of the product.*

5 mg - Container Label - NDC 64896-673-10 - dexedrine dextroamphetamine sulfate spansule susta 3

5 mg - Container Label - NDC 64896-673-10 - dexedrine dextroamphetamine sulfate spansule susta 3

The text describes the packaging and details of a medication called DEXEDRINE, containing DEXTROAMPHETAMINE SULFATE in sustained-release capsules. It is advised to store the medication in a light-resistant container at a specific temperature range. The package contains 90 capsules, and it is required by Federal Law to dispense it with the enclosed Medication Guide. Proper safety measures should be followed during dispensing. Lot No. and Expiration Date information is given.*

5 mg - Carton - NDC 64896-673-10 - dexedrine dextroamphetamine sulfate spansule susta 4

5 mg - Carton - NDC 64896-673-10 - dexedrine dextroamphetamine sulfate spansule susta 4

This text contains information about the storage and dispensing of Spansule capsules that contain destroamphetamine sulfate. The capsules are manufactured by Catalent Pharma Solutions and distributed by Amineal Specialty. They are designed to release medication promptly and gradually over an extended period of time. The package contains 90 capsules and Federal Law requires dispensing of DEXEDRINE® with the provided Medication Guide.*

10 mg - Container Label - NDC 64896-674-10 - dexedrine dextroamphetamine sulfate spansule susta 5

10 mg - Container Label - NDC 64896-674-10 - dexedrine dextroamphetamine sulfate spansule susta 5

This is a medication named DEXEDRINE which is dispensed in 90 capsules. It is a sustained-release capsule, meaning that the medication is gradually released over an extended period. This product has federal laws associated with it and must be dispensed with its medication guide provided inside the carton. The dosage must be accompanied by prescribing information. Safety precautions must be taken when dispensing this product unless directed otherwise. Lot number and expiration date are not available.*

10 mg - Carton - NDC 64896-674-10 - dexedrine dextroamphetamine sulfate spansule susta 6

10 mg - Carton - NDC 64896-674-10 - dexedrine dextroamphetamine sulfate spansule susta 6

This is a description for Dexedrine, a medication used to treat ADHD and narcolepsy. The Spansul capsule contains 15mg of dextroamphetamine sulfate, which is released promptly and gradually over an extended period. The drug should be stored between 20° and 25°C (68° and 77°F) and dispensed in a light-resistant container. Safety closures should be used, unless directed otherwise by a physician or purchaser. The accompanying prescribing information should be consulted for dosage information. It is manufactured by Catalent and distributed by Amneal Specialty. The NDC number is 64896-675-10, and this product contains 90 capsules. A medication guide is required to be provided with each bottle. The expiration date is not specified.*

15 mg - Container Label - 64896-675-10 - dexedrine dextroamphetamine sulfate spansule susta 7

15 mg - Container Label - 64896-675-10 - dexedrine dextroamphetamine sulfate spansule susta 7

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.